Bococizumab is a novel anti-PCSK9 antibody effectively developed to treat hypercholesterolemia. Such therapeutic agent works by the PCSK9 protein, a essential regulator of cholesterol amounts. By blocking the activity https://gerardxqbr893053.mpeblog.com/73136144/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia